keyword
https://read.qxmd.com/read/38650591/advanced-merkel-cell-carcinoma-in-setting-of-pembrolizumab-therapy-for-squamous-cell-carcinoma
#1
Henry Jeon, Keith Mackenzie
No abstract text is available yet for this article.
May 2024: JAAD Case Reports
https://read.qxmd.com/read/38649621/merkel-cell-carcinoma-integrating-epidemiology-immunology-and-therapeutic-updates
#2
REVIEW
Jürgen C Becker, Andreas Stang, David Schrama, Selma Ugurel
Merkel cell carcinoma (MCC) is a rare skin cancer characterized by neuroendocrine differentiation. Its carcinogenesis is based either on the integration of the Merkel cell polyomavirus or on ultraviolet (UV) mutagenesis, both of which lead to high immunogenicity either through the expression of viral proteins or neoantigens. Despite this immunogenicity resulting from viral or UV-associated carcinogenesis, it exhibits highly aggressive behavior. However, owing to the rarity of MCC and the lack of epidemiologic registries with detailed clinical data, there is some uncertainty regarding the spontaneous course of the disease...
April 22, 2024: American Journal of Clinical Dermatology
https://read.qxmd.com/read/38646410/unusual-metastasis-to-eyelid-from-extraocular-merkel-cell-carcinoma
#3
JOURNAL ARTICLE
Ahmet Özdemir, Volkan Yeter, Nurullah Koçak, Sultan Çalışkan
Merkel cell carcinoma (MCC) is an unusual skin tumor that has a significant rate of distant and local metastases. It is known that primary MCC of the eyelid usually occurs at the upper eyelid. Here we report an unusual case of MCC metastasis to the eyelid. A 63-year-old male was diagnosed with MCC three years earlier after initially presenting with a mass in his right thigh. After histopathological diagnosis, the patient received medical therapy. During treatment, he developed multiple distant metastases and a firm, purple, vascularized lesion on the upper eyelid...
April 19, 2024: Turkish Journal of Ophthalmology
https://read.qxmd.com/read/38645636/the-role-of-sentinel-lymph-node-biopsy-in-the-management-of-merkel-cell-carcinoma-a-systematic-review-and-meta-analysis
#4
JOURNAL ARTICLE
Dimitrios Kanakopoulos, Hester Lacey, Anna Payne, Maria Houlihan, Harjoat Riyat, Rhys Wheelan, Jonathan Cubitt, Joshua P Totty
BACKGROUND: Merkel cell carcinoma (MCC) is a rare cutaneous malignancy with high metastatic potential. Sentinel lymph node biopsy (SLNB) is used to assess locoregional spread, facilitate staging, and inform prognosis. Positive nodal status is associated with higher recurrence rates and reduced overall survival. METHODS: A systematic search was conducted. Eligible articles included patients diagnosed with MCC, who would be candidates for or who had SLNB. The Covidence tool was used for screening and data extraction, including additional treatments, disease-free survival, overall survival, and recurrence...
April 2024: Plastic and Reconstructive Surgery. Global Open
https://read.qxmd.com/read/38633689/pain-and-wound-management-in-fungating-merkel-cell-carcinoma-within-a-palliative-setting-the-first-case-report-of-this-predicament
#5
Shaan Mohan, Ahmad Khan
Merkel cell carcinoma (MCC) is a rare type of skin cancer of the neuroendocrine Merkel mechanoreceptors. These cells are closely associated with nerve terminals and, given their proximity to cutaneous tissue, have the propensity to develop into deeply ulcerated, fungating malignancies. These friable wounds are easily irritated, and can cause significant pain for patients. We report a palliative case of severe, fungating MCC of the left scalp where the main contributor to the patient's illness burden is pain...
2024: Indian Journal of Palliative Care
https://read.qxmd.com/read/38618960/polyomavirus-positive-merkel-cell-carcinoma-the-beginning-of-the-beginning
#6
JOURNAL ARTICLE
Michael K Wong, Cassian Yee
Merkel cell carcinoma (MCC) is an aggressive, fast-growing, highly metastatic neuroendocrine skin cancer. The Merkel cell polyomavirus (MCPyV) is an oncogenic driver in the majority of MCC tumors. In this issue of the JCI, Hansen and authors report on their tracking of CD8+ T cells reactive to MCPyV T antigen (T-Ag) in the peripheral blood of 26 patients with MCC who were undergoing frontline anti-programmed cell death protein-1 (anti-PD-1) immunotherapy. They discovered unique T cell epitopes and used the power of bar-coded tetramers to portray immune checkpoint inhibitor-induced immunogenicity as a predictor of clinical response...
April 15, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38618958/t-antigen-specific-cd8-t-cells-associate-with-pd-1-blockade-response-in-virus-positive-merkel-cell-carcinoma
#7
JOURNAL ARTICLE
Ulla Kring Hansen, Candice D Church, Ana Micaela Carnaz Simões, Marcus Svensson Frej, Amalie Kai Bentzen, Siri A Tvingsholm, Jürgen C Becker, Steven P Fling, Nirasha Ramchurren, Suzanne L Topalian, Paul T Nghiem, Sine Reker Hadrup
Merkel cell carcinoma (MCC) is a highly immunogenic skin cancer primarily induced by Merkel cell polyomavirus, which is driven by the expression of the oncogenic T antigens (T-Ags). Blockade of the programmed cell death protein-1 (PD-1) pathway has shown remarkable response rates, but evidence for therapy-associated T-Ag-specific immune response and therapeutic strategies for the nonresponding fraction are both limited. We tracked T-Ag-reactive CD8+ T cells in peripheral blood of 26 MCC patients under anti-PD1 therapy, using DNA-barcoded pMHC multimers, displaying all peptides from the predicted HLA ligandome of the oncoproteins, covering 33 class I haplotypes...
January 30, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38614786/a-rare-involvement-in-skin-cancer-merkel-cell-carcinoma-with-bone-marrow-infiltration-in-a-kidney-transplant-recipient
#8
Oyku Durmus, Ozay Gokoz, Emine Arzu Saglam, Eser Lay Ergun, Duygu Gulseren
A 60-year-old man presented with a painless, rapidly growing, haemorrhagic pink nodule on the posterior of his thigh that had developed 1 month previously. He had a diagnosis of IgA nephropathy and had received a renal allograft 7 years before. An excisional biopsy was performed and the diagnosis of Merkel cell carcinoma (MCC) was made. No distant metastases was detected. 10 months after first presentation, due to the development of acute pancytopenia and concomitant FDG PET/CT findings compatible with disease progression, bone marrow biopsy was performed which revealed metastasis of MCC...
May 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38604100/metastatic-merkel-cell-carcinoma-to-the-thyroid-gland-case-report-and-review-of-the-literature
#9
REVIEW
Salmaan Sayeed, Danielle Kapustin, Samuel J Rubin, Jun Fan, Christina Wiedmer, Daniel Chung, Azita Khorsandi, Margaret Brandwein-Weber, Philip Friedlander, Richard Bakst, Ricardo J Ramirez, Mark L Urken
BACKGROUND: Merkel cell carcinoma (MCC) is an aggressive and rare neuroendocrine tumor, accounting for less than 1% of skin cancers. Metastasis primarily manifests in the cervical lymph nodes but rarely affect the thyroid. METHODS: We report a case of primary head and neck cutaneous MCC with metastasis to the thyroid gland. A review of the literature of MCC with thyroid metastasis was conducted. RESULTS: We identified five cases of MCC with thyroid metastasis...
April 4, 2024: American Journal of Otolaryngology
https://read.qxmd.com/read/38596400/merkel-cell-carcinoma-masquerading-clinically-as-a-cyst-in-a-young-patient
#10
Harty Elouise Ashby, Grayson N Jones, Oon Leedhanachoke, Phillip Jen, Noah Helphenstine, Fadi Al Akhrass
Merkel cell carcinoma (MCC) is an extremely rare and aggressive tumor. Here we report an unusual MCC that manifested as an abruptly enlarging, painful skin lesion over the right antecubital fossa and masqueraded as an epidermal cyst in a 42-year-old male. The lesion was surgically excised and subjected to histopathologic and immunohistochemical examinations. The subsequent analysis allowed for the diagnosis of MCC. Clinicians should always be cognizant of MCC, which can be easily misdiagnosed. Early diagnosis and appropriate treatment are keys to improving the survival rates of MCC patients...
2024: International Medical Case Reports Journal
https://read.qxmd.com/read/38594829/p16-overexpression-identifies-oncogenic-high-risk-hpv-infection-in-non-oropharyngeal-squamous-cell-carcinoma-of-the-head-and-neck
#11
JOURNAL ARTICLE
Anne-Sophie Becker, Jenny Merkel, Inci Bozkurt, Daniel Fabian Strüder, Claudia Maletzki, Maja Hühns, Annette Helene Zimpfer
BACKGROUND: Human papillomavirus (HPV) is an increasing risk factor for cancer. HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) is associated with a favorable outcome. Blockstaining for p16 is a surrogate marker for HPV+ OPSCC. In oral and laryngeal squamous cell carcinoma (OSCC/LSCC), the relevance of p16 immunohistochemistry, alone or in combination with other cell cycle-related proteins, to identify HPV-driven non-OPSCC is less well understood. METHODS: We stained for p16, pRb, cyclin D1, and p53 in 327 HNSCC...
April 9, 2024: Head & Neck
https://read.qxmd.com/read/38590555/personalized-treatment-concepts-in-extraocular-cancer
#12
REVIEW
Sitong Ju, Alexander C Rokohl, Yongwei Guo, Ke Yao, Wanlin Fan, Ludwig M Heindl
BACKGROUND: The periocular skin is neoplasms-prone to various benign and malignant. Periocular malignancies are more aggressive and challenging to cure and repair than those in other skin areas. In recent decades, immunotherapy has significantly advanced oncology, allowing the autoimmune system to target and destroy malignant cells. Skin malignancies, especially periocular tumors, are particularly sensitive to immunotherapy. This technique has dramatically impacted the successful treatment of challenging tumors...
2024: Adv Ophthalmol Pract Res
https://read.qxmd.com/read/38587336/first-line-immunotherapy-for-metastatic-merkel-cell-carcinoma-analysis-of-real-world-survival-data-and-practice-patterns
#13
JOURNAL ARTICLE
Hanna Kakish, James Sun, John B Ammori, Richard S Hoehn, Luke D Rothermel
BACKGROUND: Immune checkpoint inhibitors are a promising new therapy for advanced Merkel Cell Carcinoma (MCC). We investigated real-world utilization and survival outcomes of first-line immunotherapies in a contemporary cohort. METHODS: Using the National Cancer Database (NCDB), we identified 759 patients with MCC between 2015 and 2020 with stage IV disease and known status of first-line systemic therapy. Univariable and multivariable analyses were used to determine predictors of immunotherapy usage...
April 8, 2024: American Journal of Clinical Oncology
https://read.qxmd.com/read/38586682/hiding-in-plain-sight-an-atypical-presentation-of-the-uncommon-merkel-cell-carcinoma
#14
Elisha Myers, Matthew Uhde
Merkel cell carcinoma (MCC) is a cutaneous neoplasm that is challenging to diagnose secondary to its rarity. We report a case involving a 76-year-old Caucasian female with a seemingly benign skin nodule on her right forearm. Histopathological analysis revealed characteristics of MCC, including uniform round cells with minimal cytoplasm and fine granular chromatin. Immunohistochemical staining confirmed insulinoma-associated protein 1 (INSM1) positivity, a marker with high sensitivity and specificity in localized MCC diagnosis...
March 2024: Curēus
https://read.qxmd.com/read/38586649/rare-but-still-there-an-interesting-case-of-cytokeratin-20-negative-merkel-cell-carcinoma
#15
Amna Zahid, Arsalan Sheikh
Merkel cell carcinoma (MCC) of the skin is a rare and aggressive primary neuroendocrine tumor that mainly involves sun-exposed areas and can metastasize to other parts of the body. Due to varied clinical features and the sharing of similar histological features with other neuroendocrine tumors, diagnosis can be challenging. Therefore, immunohistochemistry plays an important role in diagnosis, and the characteristic perinuclear staining with cytokeratin 20 (CK 20) helps to differentiate it from other morphologically similar tumors, especially metastatic small cell carcinoma of the lung...
March 2024: Curēus
https://read.qxmd.com/read/38574506/corrigendum-to-characterizing-the-therapeutic-potential-of-a-potent-bet-degrader-in-merkel-cell-carcinoma-neoplasia-volume-21-issue-3-2019-322-330
#16
Jae Eun Choi, Monique E Verhaegen, Sahr Yazdani, Rohit Malik, Paul W Harms, Doris Mangelberger, Jean Tien, Xuhong Cao, Yuping Wang, Marcin Cieślik, Jonathan Gurkan, Mishaal Yazdani, Xiaojun Jing, Kristin Juckette, Fengyun Su, Rui Wang, Bing Zhou, Ingrid J Apel, Shaomeng Wang, Andrzej A Dlugosz, Arul M Chinnaiyan
No abstract text is available yet for this article.
April 3, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38555263/presence-of-merkel-cell-polyomavirus-dna-and-large-t-antigen-in-keratinocyte-carcinomas-and-its-correlation-with-immunohistochemical-markers-p16-p53-and-ki67
#17
JOURNAL ARTICLE
T R Bellott, Flávio Barbosa Luz, Anna Karoline Fausto da Silva, Rafael Brandão Varella, Mayra Carrijo Rochael, Rafaela Elvira Rozza-de-Menezes, Luciana Pantaleão
BACKGROUND: Merkel cell polyomavirus (MCPyV), a human polyomavirus that is unequivocally linked to merkel cell carcinoma (MCC), has been found in association with keratinocytes carcinomas (KC), especially basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC). Nevertheless, there is scarce information about the possible involvement of MCPyV in the development of KC. OBJECTIVES: To assess the presence of MCPyV DNA and Large-T Antigen (LT-Ag) via Polymerase Chain Reaction (PCR) and Immunohistochemistry (IHC) in cases of KC, and to correlate its presence with immunohistochemical markers p16, p53, and ki67, tumor type and subtype, sun-exposed location, and epidemiological data...
March 29, 2024: Anais Brasileiros de Dermatologia
https://read.qxmd.com/read/38543781/human-oncogenic-viruses-characteristics-and-prevention-strategies-lessons-learned-from-human-papillomaviruses
#18
REVIEW
Luisa Galati, Maria Vincenza Chiantore, Mariarosaria Marinaro, Paola Di Bonito
Approximately 12% of human cancers worldwide are associated with infectious agents, which are classified by the International Agency for Research on Cancer (IARC) as Group 1 within the agents that are carcinogenic to humans. Most of these agents are viruses. Group 1 oncogenic viruses include hepatitis C virus, hepatitis B virus (HBV), human T-cell lymphotropic virus type 1, Epstein-Barr virus, Kaposi sarcoma-associated herpesvirus, human immunodeficiency virus-1 and high-risk human papillomaviruses (HPVs). In addition, some human polyomaviruses are suspected of inducing cancer prevalently in hosts with impaired immune responses...
March 8, 2024: Viruses
https://read.qxmd.com/read/38532566/analyses-of-tertiary-lymphoid-structures-observed-in-cases-of-merkel-cell-carcinoma-showing-spontaneous-regression
#19
JOURNAL ARTICLE
Motoki Nakamura, Maki Yoshimitsu, Tetsuya Magara, Shinji Kano, Hiroshi Kato, Akimichi Morita
Merkel cell carcinoma (MCC) is a high-grade skin cancer, but spontaneous regression is observed at a markedly higher frequency than in other carcinomas. Although spontaneous regression is a phenomenon that greatly impacts treatment planning, we still cannot predict it. We previously reported on the prognostic impact of the presence or absence of tertiary lymphoid structures (TLS) and of Merkel cell polyomavirus (MCPyV) infection. To learn more about the spontaneous regression of MCC, detailed analyses were performed focusing on spontaneous regression cases...
March 2024: Experimental Dermatology
https://read.qxmd.com/read/38512218/merkel-cell-carcinoma-on-the-face-a-case-report
#20
JOURNAL ARTICLE
Shaikha Salah Alhaj, Fatma Abdulghaffar Qaderi, Tarek Ibrahim, Maha Almohammad
Background: Merkel cell carcinoma (MCC) is a rare primary neuroendocrine skin tumor that represents a flesh-colored or bluish-red nodule on the face, neck, or head. Long-term Ultraviolet (UV) radiation exposure and Merkel cell polyomavirus (MCV) are associated with Merkel cell carcinoma pathogenesis. We present a case of Merkel cell carcinoma in an 87-year-old male patient in the right cheek. Objective: The primary goal of presenting the case was to bring Merkel cell carcinoma, which is a diagnostic challenge, to the notice of dermatologists and oncologists, as early detection and prompt treatment are important...
March 17, 2024: JMIR dermatology
keyword
keyword
5085
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.